Tags

Type your tag names separated by a space and hit enter

ACE2 Expression Is Upregulated in Inflammatory Corneal Epithelial Cells and Attenuated by Resveratrol.
Invest Ophthalmol Vis Sci. 2021 06 01; 62(7):25.IO

Abstract

Purpose

The ocular surface is considered an important route for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. The expression level of the SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) is vital for viral infection. However, the regulation of ACE2 expression on the ocular surface is still unknown. We aimed to determine the change in ACE2 expression in inflamed corneal epithelium and explore potential drugs to reduce the expression of ACE2 on the ocular surface.

Methods

The expression of the SARS-CoV-2 receptors ACE2 and TMPRSS2 in human corneal epithelial cells (HCECs) was examined by qPCR and Western blotting. The altered expression of ACE2 in inflammatory corneal epithelium was evaluated in TNFα- and IL-1β-stimulated HCECs and inflamed mouse corneal epithelium, and the effect of resveratrol on ACE2 expression in HCECs was detected by immunofluorescence and Western blot analysis.

Results

ACE2 and TMPRSS2 are expressed on the human corneal epithelial cells. ACE2 expression is upregulated in HCECs by stimulation with TNFα and IL-1β and inflamed mouse corneas, including dry eye and alkali-burned corneas. In addition, resveratrol attenuates the increased expression of ACE2 induced by TNFα in HCECs.

Conclusions

This study demonstrates that ACE2 is highly expressed in HCECs and can be upregulated by stimulation with inflammatory cytokines and inflamed mouse corneal epithelium. Resveratrol may be able to reduce the increased expression of ACE2 on the inflammatory ocular surface. Our work suggests that patients with an inflammatory ocular surface may display higher ACE2 expression, which increases the risk of SARS-CoV-2 infection.

Authors+Show Affiliations

Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin, China. Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China. Nankai University Affiliated Eye Hospital, Tianjin, China.Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China.Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin, China. Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China. Nankai University Affiliated Eye Hospital, Tianjin, China.Ningcheng Center Hospital of Chifeng City, Chifeng, China.Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin, China. Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China. Nankai University Affiliated Eye Hospital, Tianjin, China.Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China.Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin, China. Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China. Nankai University Affiliated Eye Hospital, Tianjin, China. State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin, China. Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China. Nankai University Affiliated Eye Hospital, Tianjin, China.Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin, China. Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China. Nankai University Affiliated Eye Hospital, Tianjin, China.Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin, China. Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China. Nankai University Affiliated Eye Hospital, Tianjin, China.Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin, China. Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China. Nankai University Affiliated Eye Hospital, Tianjin, China.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

34160563

Citation

Jiang, Zhixin, et al. "ACE2 Expression Is Upregulated in Inflammatory Corneal Epithelial Cells and Attenuated By Resveratrol." Investigative Ophthalmology & Visual Science, vol. 62, no. 7, 2021, p. 25.
Jiang Z, Zhang H, Gao J, et al. ACE2 Expression Is Upregulated in Inflammatory Corneal Epithelial Cells and Attenuated by Resveratrol. Invest Ophthalmol Vis Sci. 2021;62(7):25.
Jiang, Z., Zhang, H., Gao, J., Yu, H., Han, R., Zhu, L., Chen, X., Fan, Q., Hao, P., Wang, L., & Li, X. (2021). ACE2 Expression Is Upregulated in Inflammatory Corneal Epithelial Cells and Attenuated by Resveratrol. Investigative Ophthalmology & Visual Science, 62(7), 25. https://doi.org/10.1167/iovs.62.7.25
Jiang Z, et al. ACE2 Expression Is Upregulated in Inflammatory Corneal Epithelial Cells and Attenuated By Resveratrol. Invest Ophthalmol Vis Sci. 2021 06 1;62(7):25. PubMed PMID: 34160563.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - ACE2 Expression Is Upregulated in Inflammatory Corneal Epithelial Cells and Attenuated by Resveratrol. AU - Jiang,Zhixin, AU - Zhang,Huan, AU - Gao,Juan, AU - Yu,Hao, AU - Han,Ruifang, AU - Zhu,Lin, AU - Chen,Xi, AU - Fan,Qian, AU - Hao,Peng, AU - Wang,Liming, AU - Li,Xuan, PY - 2021/6/23/entrez PY - 2021/6/24/pubmed PY - 2021/7/6/medline SP - 25 EP - 25 JF - Investigative ophthalmology & visual science JO - Invest Ophthalmol Vis Sci VL - 62 IS - 7 N2 - Purpose: The ocular surface is considered an important route for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. The expression level of the SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) is vital for viral infection. However, the regulation of ACE2 expression on the ocular surface is still unknown. We aimed to determine the change in ACE2 expression in inflamed corneal epithelium and explore potential drugs to reduce the expression of ACE2 on the ocular surface. Methods: The expression of the SARS-CoV-2 receptors ACE2 and TMPRSS2 in human corneal epithelial cells (HCECs) was examined by qPCR and Western blotting. The altered expression of ACE2 in inflammatory corneal epithelium was evaluated in TNFα- and IL-1β-stimulated HCECs and inflamed mouse corneal epithelium, and the effect of resveratrol on ACE2 expression in HCECs was detected by immunofluorescence and Western blot analysis. Results: ACE2 and TMPRSS2 are expressed on the human corneal epithelial cells. ACE2 expression is upregulated in HCECs by stimulation with TNFα and IL-1β and inflamed mouse corneas, including dry eye and alkali-burned corneas. In addition, resveratrol attenuates the increased expression of ACE2 induced by TNFα in HCECs. Conclusions: This study demonstrates that ACE2 is highly expressed in HCECs and can be upregulated by stimulation with inflammatory cytokines and inflamed mouse corneal epithelium. Resveratrol may be able to reduce the increased expression of ACE2 on the inflammatory ocular surface. Our work suggests that patients with an inflammatory ocular surface may display higher ACE2 expression, which increases the risk of SARS-CoV-2 infection. SN - 1552-5783 UR - https://www.unboundmedicine.com/medline/citation/34160563/ACE2_Expression_Is_Upregulated_in_Inflammatory_Corneal_Epithelial_Cells_and_Attenuated_by_Resveratrol_ DB - PRIME DP - Unbound Medicine ER -